Price $86.31 |
Market Cap
5.62B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
5.1
|
P/B
1.2
|
P/S
1.89
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
4.5
|
Op. Cash Flow
1.04M
|
FCF
19.2
|
|
Op. Margin
36.60%
|
Net Margin
26.70%
|
ROE
23.00%
|
ROI
36.80%
|
|
ROA
14.10%
|
EPS Growth
-18.60%
|
Current Ratio
4.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acorda Therapeutics Inc (ACOR) | $0.94 | - | - | 16.2M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $0.67 | - | - | 93M | Strong Buy |
| Akumin Inc (AKU) | $0.97 | - | - | 62.6M | Strong Buy |
| Alimera Sciences Inc (ALIM) | $2.61 | - | - | 17.3M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $2.14 | - | - | 604.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
